Guidelines Detail

Navbar

Guidelines
Compendia & Templates
Education & Research
Patient Resources
Business & Policy
Global

Guidelines Treatment by Cancer Type Detection, Prevention, and Risk Reduction Supportive Care Specific Populations Guidelines for Patients Guidelines With Evidence Blocks Framework for Resource Stratification Harmonized Guidelines International Adaptations and Translations Guidelines Process Guidelines Panels and Disclosure Submissions, Licensing, and Permissions Recently Updated Guidelines

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Anal Carcinoma Basal Cell Skin Cancer B-Cell Lymphomas Bladder Cancer Bone Cancer Breast Cancer Central Nervous System Cancers Cervical Cancer Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic Myeloid Leukemia Colon Cancer Dermatofibrosarcoma Protuberans Esophageal and Esophagogastric Junction Cancers Gastric Cancer Gastrointestinal Stromal Tumors (GIST) Gestational Trophoblastic Neoplasia Hairy Cell Leukemia Head and Neck Cancers

Hepatobiliary Cancers Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma Kidney Cancer Malignant Pleural Mesothelioma Melanoma: Cutaneous Melanoma: Uveal Merkel Cell Carcinoma Multiple Myeloma Myelodysplastic Syndromes Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Fusion Genes Myeloproliferative Neoplasms Neuroendocrine and Adrenal Tumors Non-Small Cell Lung Cancer Occult Primary Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma Pediatric Acute Lymphoblastic Leukemia Pediatric Aggressive Mature B-Cell Lymphomas

Pediatric Hodgkin Lymphoma Penile Cancer Primary Cutaneous Lymphomas Prostate Cancer Rectal Cancer Small Bowel Adenocarcinoma Small Cell Lung Cancer Soft Tissue Sarcoma Squamous Cell Skin Cancer Systemic Light Chain Amyloidosis Systemic Mastocytosis T-Cell Lymphomas Testicular Cancer Thymomas and Thymic Carcinomas Thyroid Carcinoma Uterine Neoplasms Vulvar Cancer Waldenström Macroglobulinemia / Lymphoplasmacytic Lymphoma Wilms Tumor (Nephroblastoma)

Breast Cancer Risk Reduction Breast Cancer Screening and Diagnosis Colorectal Cancer Screening

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Genetic/Familial High-Risk Assessment: Colorectal Lung Cancer Screening

Prostate Cancer Early Detection

Adult Cancer Pain Antiemesis Cancer-Associated Venous Thromboembolic Disease Cancer-Related Fatigue

Distress Management Hematopoietic Cell Transplantation Hematopoietic Growth Factors Management of Immunotherapy-Related Toxicities

Palliative Care Prevention and Treatment of Cancer-Related Infections Smoking Cessation Survivorship

Adolescent and Young Adult (AYA) Oncology

Cancer in People with HIV

Older Adult Oncology

Acute Lymphoblastic Leukemia (adult) Acute Lymphoblastic Leukemia (pediatric) Acute Myeloid Leukemia Adolescents and Young Adults with Cancer Anemia and Neutropenia - Low Red and White Blood Cell Counts Bladder Cancer Bone Cancer Brain Cancer/Gliomas Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Colon Cancer DCIS Breast Cancer Diffuse Large B-Cell Lymphoma Distress During Cancer Care Early and Locally Advanced Lung Cancer Esophageal Cancer Follicular Lymphoma Gallbladder and Bile Duct Cancers Hodgkin Lymphoma

Immunotherapy Side Effects: CAR T-Cell Therapy Immunotherapy Side Effects: Immune Checkpoint Inhibitors Invasive Breast Cancer Kidney Cancer Liver Cancer Lung Cancer Screening Malignant Pleural Mesothelioma Mantle Cell Lymphoma Melanoma Metastatic Breast Cancer Multiple Myeloma Mycosis Fungoides/Sézary Syndrome Myelodysplastic Syndromes Myeloproliferative Neoplasms Nasopharyngeal Cancer Nausea and Vomiting Neuroendocrine Tumors Non-Small Cell Lung Cancer - Metastatic Oral Cancers

Oropharyngeal Cancer Ovarian Cancer Pancreatic Cancer Peripheral T-Cell Lymphoma Primary Central Nervous System Lymphoma Primary Cutaneous Lymphomas Prostate Cancer: Advanced Stage Prostate Cancer: Early Stage Rectal Cancer Soft Tissue Sarcoma Squamous Cell Skin Cancer Stomach Cancer Survivorship Care for Cancer-Related Late and Long-Term Effects Survivorship Care for Healthy Living Thyroid Cancer Uterine Cancer Waldenström Macroglobulinemia

About Clinical Practice Guidelines Development and Update of Guidelines

Transparency Process Guidelines Panels Meeting Schedule

Disclosure Policies and Potential Conflicts of Interest

Guidelines Panels

Guideline Steering Committee

Licensing and Permissions Permissions Linking Permissions Distress Tool

Permissions Request Form Submission Request to the Guidelines Panels Submission Request History

Academic Publication Information

Compendia & Templates Compendia Chemotherapy Order Templates

NCCN Compendia Drugs and Biologics Compendium Biomarkers Compendium

Imaging AUC Compendium Radiation Therapy Compendium Subscribe to NCCN Compendium

Recognition Program

Browse by Cancer Type View Chemotherapy Order Templates User Guide

EHR Integration Chemotherapy Order Templates Committee

Subscribe to NCCN Templates Chemotherapy Order Templates Reviewer Acknowledgement

Education & Research Events and Programs Oncology Research Program JNCCN Publications

Calendar of Events Continuing Education

Annual Conference Annual Congress: Hematologic Malignancies

Oncology Research Program (ORP) Current Opportunities ORP Recent News ORP Grant History

Scientific Publications Clinical Trials Informed Consent Language Database Best Practices for Biorepositories

Shared Resources Disclosure Policy

About JNCCN

Subscribe to JNCCN

JNCCN Email Updates

Business & Policy Business Policy and Advocacy Program

Corporate Council Academy Trends U.S. Surveys Trends Global Surveys Flash Updates

Order Free Pocket Guidelines and Guidelines for Patients Advertising Opportunities Research Tools: REMS Employer Resources Virtual Reimbursement Resource Room and App

Health Information Technology Licenses Embargo Policy Firewall Policy

Policy and Advocacy Program Oncology Policy Summits

Policy Priority: Improve and Facilitate Quality Cancer Care Policy Priority: Ensure Patient Accessibility

Policy Priority: Increase Use of Guidelines State Oncology Society Forum

Global Global Clinical Resources Global Support Opportunities Contact NCCN Global Global Events

NCCN Framework For Resource Stratification Harmonized Guidelines

International Adaptations and Translations Regions

Global Corporate Council Global Academy

Trends Global Surveys eBulletin Global Edition

Home
Guidelines
Guidelines Detail

NCCN Guidelines

Treatment by Cancer Type
Detection, Prevention, and Risk Reduction
Supportive Care
Specific Populations
Guidelines for Patients
Guidelines With Evidence Blocks
Framework for Resource Stratification
Harmonized Guidelines
International Adaptations and Translations
Guidelines Process
Guidelines Panels and Disclosure
Submissions, Licensing, and Permissions
Recently Updated Guidelines

Myelodysplastic Syndromes

Guidelines

NCCN Guidelines Version 3.2021

- MDS/MPN Overlap Neoplasms

- Myelodysplastic Syndromes

Evidence Blocks

NCCN Guidelines with Evidence Blocks Version 3.2021

Guidelines for Patients

Myelodysplastic Syndromes-English Version 2021
Myelodysplastic Syndromes-Spanish Version 2021
Myelodysplastic Syndromes-Spanish - Latin America Version 2021

Disclosures

Disclosure Policy
Panel Member Disclosures
Panel Member Disclosures by Meeting Date
End User License Agreement